Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
FDA grants Breakthrough Device Designation to BioAgilytix’s anti-AAV antibody assay supporting Lexeo’s gene therapy for ...
Qure (NasdaqGS:QURE) released updated clinical data for its gene therapy candidate AMT-191 in Fabry disease and paused new dosing to review safety findings. The company is also facing a newly filed ...
According to MarketsandMarkets™, the Leukapheresis Market is projected to grow from about USD 90.6 million in 2026 to USD 138 ...
HONG KONG SAR, HONG KONG, February 2, 2026 /EINPresswire.com/ -- Mstone Partners Healthcare (“Mstone”), a Hong ...
Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 12:30 PM ESTCompany ParticipantsR.
Scientists in China report removing HIV from human DNA using gene-editing technology. Experts say the findings are promising but still far from a confirmed cure.
Vietnam Investment Review on MSN
APAO 2026 ophthalmology congress wraps successfully
HONG KONG SAR - Media OutReach Newswire - 13 February 2026 - The four-day "APAO 2026 Asia-Pacific Academy of Ophthalmology (APAO) Congress" successfully concluded last week, marking a significant ...
Madrigal is eying an expansion of MASH blockbuster Rezdiffra’s capabilities via combination with precision siRNA gene ...
HONG KONG SAR - Media OutReach Newswire - 13 February 2026 - The four-day "APAO 2026 Asia-Pacific Academy of Ophthalmology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results